Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof

Details for Australian Patent Application No. 2005219779 (hide)

Owner Kissei Pharmaceutical Co., Ltd.

Inventors Isaji, Masayuki; Fushimi, Nobuhiko; Fujikura, Hideki

Agent Spruson & Ferguson

Pub. Number AU-B-2005219779

PCT Pub. Number WO2005/085237

Priority 2004-61428 04.03.04 JP

Filing date 3 March 2005

Wipo publication date 15 September 2005

Acceptance publication date 14 April 2011

International Classifications

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/404 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/06 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 407/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/085237 Priority application(s): WO2005/085237

14 April 2011 Application Accepted

  Published as AU-B-2005219779

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219784-Pyridone derivative

2005219777-Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof